Guardant Health Announces Executive Officer Changes
Ticker: GH · Form: 8-K · Filed: Apr 27, 2026 · CIK: 0001576280
| Field | Detail |
|---|---|
| Company | Guardant Health, Inc. (GH) |
| Form Type | 8-K |
| Filed Date | Apr 27, 2026 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-changes, management-update, sec-filing
Related Tickers: GH
TL;DR
Guardant Health (GH) filed an 8-K on 4/27/26 for exec changes. Watch for details.
AI Summary
On April 27, 2026, Guardant Health, Inc. filed an 8-K report detailing a change in its executive officer structure. The filing specifically addresses Item 5.02, which pertains to the departure or election of directors and officers, and any related compensatory arrangements. No specific names or dollar amounts were immediately available in the provided text, but the filing indicates a formal update to the company's leadership team.
Why It Matters
Changes in executive officers can signal shifts in company strategy, operational focus, or financial performance, impacting investor confidence and stock valuation.
Risk Assessment
Risk Level: medium — Executive changes can introduce uncertainty regarding future company direction and performance, potentially affecting stock price.
Key Players & Entities
- Guardant Health, Inc. (company) — Filer of the 8-K report
- 0001576280 (company) — CIK number for Guardant Health, Inc.
- 2026-04-27 (date) — Filing date and period of report
- Item 5.02 (filing_item) — Specific section of the 8-K report concerning officer and director changes
FAQ
What specific executive officer positions were affected by the changes reported in the 8-K filing?
The provided text states the filing addresses Item 5.02, which covers 'Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers,' but does not specify which individuals or roles were impacted.
Were there any new appointments or departures of directors mentioned in the filing?
The filing indicates that Item 5.02, concerning director and officer changes, is being addressed, but the specific details of any new appointments or departures are not included in the provided excerpt.
Does the filing mention any new compensatory arrangements for the officers involved?
The filing's description of Item 5.02 includes 'Compensatory Arrangements of Certain Officers,' suggesting this topic may be covered, but the specific details of these arrangements are not present in the provided text.
What is the significance of filing an 8-K on April 27, 2026, for Guardant Health?
Filing an 8-K on April 27, 2026, signifies a material event for Guardant Health, Inc., specifically related to changes in its senior leadership or board of directors, requiring prompt disclosure to the public.
Where is Guardant Health, Inc. located based on the filing information?
Guardant Health, Inc.'s mailing and business address is listed as 3100 HANOVER STREET, PALO ALTO, CA 94304.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 27, 2026 regarding Guardant Health, Inc. (GH).